Immunitor publishes interim results from Phase III trial of oral...

The Immunitor study is published in January issue of Hepatoma Research (ClinicalTrials.gov Identifier: NCT02232490).(PRWeb February 01, 2020)Read the full story at https://www.prweb.com/releases/immunitor_publishes_interim_results_from_phase_iii_trial_of_oral_immunotherapy_for_liver_cancer/prweb16874458.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news